1. Home
  2. AVAV vs KRYS Comparison

AVAV vs KRYS Comparison

Compare AVAV & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AeroVironment Inc.

AVAV

AeroVironment Inc.

N/A

Current Price

$144.32

Market Cap

8.8B

Sector

Industrials

ML Signal

N/A

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

N/A

Current Price

$356.52

Market Cap

9.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVAV
KRYS
Founded
1971
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
9.6B
IPO Year
2006
2017

Fundamental Metrics

Financial Performance
Metric
AVAV
KRYS
Price
$144.32
$356.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
11
Target Price
$316.88
$297.60
AVG Volume (30 Days)
1.2M
184.9K
Earning Date
03-10-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
128.00
EPS
N/A
3.62
Revenue
N/A
$389,130,000.00
Revenue This Year
$135.55
$38.74
Revenue Next Year
$14.90
$32.53
P/E Ratio
N/A
$102.13
Revenue Growth
N/A
33.94
52 Week Low
$135.20
$145.46
52 Week High
$417.86
$382.54

Technical Indicators

Market Signals
Indicator
AVAV
KRYS
Relative Strength Index (RSI) 38.33 62.80
Support Level $138.24 $253.89
Resistance Level $162.30 $382.33
Average True Range (ATR) 7.81 10.15
MACD -2.80 3.30
Stochastic Oscillator 7.54 91.64

Price Performance

Historical Comparison
AVAV
KRYS

About AVAV AeroVironment Inc.

AeroVironment Inc is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploys autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. The company operates business in two reportable segments: Autonomous Systems (AxS) and Space, Cyber and Directed Energy (SCDE). It derives majority of revenue from Autonomous Systems segment focuses on the design, development, production, delivery, and support of intelligent, multi-domain robotic systems, including UAS, uncrewed underwater vehicles and ground robot systems. Geographically it derives the majority of revenue from domestic operations.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: